Vector Science and Therapeutics Corp.
PAIN.V
TSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -2.59M | -241.10K | -987.80K | ||
| Total Depreciation and Amortization | 7.50K | 3.30K | 2.60K | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 1.52M | -78.20K | 72.70K | ||
| Change in Net Operating Assets | 255.30K | -836.20K | 79.60K | ||
| Cash from Operations | -808.20K | -1.15M | -832.80K | ||
| Capital Expenditure | -47.10K | -1.70K | -83.10K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | 23.40K | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -11.30K | -1.40K | -14.20K | ||
| Cash from Investing | -35.00K | -3.10K | -97.40K | ||
| Total Debt Issued | -600.00 | -200.00 | 800.00 | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 1.75M | -- | 125.30K | ||
| Repurchase of Common Stock | -- | -34.20K | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -594.70K | 0.00 | -25.70K | ||
| Cash from Financing | 1.15M | -34.40K | 100.40K | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 310.50K | -1.19M | -829.80K | ||